Bausch + Lomb Corporation

Healthcare

NYSE:BLCO · New York Stock Exchange

Market Cap $5.44B Beta 0.57 P/E (TTM) -24.5

$15.08 -1.31%

-$0.20 today

52W Low $11.44High $18.92

Vol 0.23M · Avg 0.47M

EPS (TTM)-$0.62

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+22.30%

Period High

$18.60

Period Low

$11.55

Latest

$15.08

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

$10.48B

TG Therapeutics, Inc.

NASDAQ:TGTX

$7.59B

Glaukos Corporation

NYSE:GKOS

$7.45B

Oscar Health, Inc.

NYSE:OSCR

$7.31B

Vaxcyte, Inc.

NASDAQ:PCVX

$6.87B

Arcellx, Inc.

ACLX

$6.73B

PTC Therapeutics, Inc.

NASDAQ:PTCT

$6.23B

Teleflex Incorporated

NYSE:TFX

$5.78B

CRISPR Therapeutics AG

NASDAQ:CRSP

$4.82B

Merit Medical Systems, Inc.

NASDAQ:MMSI

$3.98B

What is the latest BLCO filing?

The latest filing shown is SD dated Jun 1, 2026.

How many recent filings does BLCO have?

Intrinsic Alpha currently shows 20 recent filings for BLCO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.